Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ENVERIC BIOSCIENCES, INC. | |
| March 28, 2025 | By: | /s/ Joseph Tucker |
|---|
| Joseph Tucker, Ph.D. |
| Chief Executive Officer |
| (Principal Executive Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| March 28, 2025 | By: | /s/ Joseph Tucker |
|---|
| Joseph Tucker, Ph.D. |
| Chief Executive Officer |
| (Principal Executive Officer) |
| March 28, 2025 | By: | /s/ Kevin Coveney |
|---|
| Kevin Coveney |
| Chief Financial Officer |
| (Principal Financial and Accounting Officer) |
| March 28, 2025 | By: | /s/ Michael Webb |
|---|
| Michael Webb |
| Director |
| March 28, 2025 | By: | /s/ George Kegler |
|---|
| George Kegler |
| Director |
| March 28, 2025 | By: | /s/ Marcus Schabacker |
|---|
| Marcus Schabacker, Ph.D., M.D. |
| Director |
| March 28, 2025 | By: | /s/ Frank Pasqualone |
|---|
| Frank Pasqualone |
| Director |
| March 28, 2025 | By: | /s/ Sheila DeWitt |
|---|
| Sheila DeWitt, Ph.D. |
| Director |
